Ongoing Task Forces

Task Force Number	Task Force Name	Task Force Chairs
TF-2021-17	ERS Statement on preschool wheezing disorders: knowledge gaps, update definitions and outline future directions	Sejal Saglani, Padmaja Subbarao
TF-2021-16	ERS Clinical Practice Guidelines on diagnosis and management of Pulmonary Alveolar Proteinosis	Cormac McCarthy, Francesco Bonella
TF-2021-14	ERS Statement on transition of paediatric patients with interstitial lung disease to the adult care	Petr Pohunek, Effrosyne Manali
TF-2021-10	Core outcome set for trials evaluating the management of pneumonia – an ERS Statement	Timothy Felton, Tobias Welte
TF-2021-09	Developing Global Lung Function Initiative (GLI) reference equations for cardiopulmonary exercise testing (CPET) – an ERS Technical Standard	Karl Sylvester, Helge Hebestreit
TF-2021-08	ERS Clinical Practice Guidelines on Symptom Management in advanced lung disease	Anne Holland, Magnus Ekström, Natasha Smallwood
TF-2021-06	ERS Statement on “Benign” Pleural Effusions	Najib Rahman, Giuseppe Cardillo
TF-2021-05	ERS Statement on Advanced Telemedicine for Sleep Disordered Breathing	Maria Bonsignore, Johan Verbraecken
TF-2021-03	ERS Clinical Practice Guideline on Weaning from Mechanical Ventilation	Martin Dres, Paolo Navalesi
TF-2021-01	ERS/EBMT Clinical Practice Guidelines on treatment of pulmonary chronic graft versus host disease	Robin Vos, Daiana Stolz, Saskia Bos
TF-2020-22	ERS Guideline on ICS/formoterol on demand	Alberto Papi, Florence Schleich, Diogenes Ferreira
TF-2020-18	ERS Technical Standard for a comprehensive high-quality lung cancer CT screening programme	David Baldwin, Jan Van Meerbeeck
TF-2020-17	ERS Statement on defining respiratory exacerbations for bronchiectasis in children and adolescents	Anne Chang, Ahmad Kantar
TF-2020-15	ERS Statement on frailty in adults with chronic lung disease	Matthew Maddocks, Christian Osadnik
TF-2020-14	ERS Guidelines for management of COVID-19	Nicolas Roche, James Chalmers
TF-2020-13	ERS/ESC Guidelines on pulmonary hypertension	Marion Delcroix, Stephan Rosenkranz
TF-2020-11	ERS/ESTS Statement on management of pleural infection	Isabelle Schmitt-Opitz, Najib Rahman, Eihab Bedawi
TF-2020-10	ERS Clinical Practice Guideline on various aspects of quality in lung cancer care	Torsten Blum, Thierry Berghmans, Adrian Constantini
TF-2020-07	ERS/ESTS Clinical Practice Guideline Task Force on fitness for tumour-specific treatments of lung cancer	Alessandro Brunelli, Huber Rodolfo Maria, Georgia Hardavella
TF-2020-06	ERS Statement on dyspnoea: a multidimensional and multidisciplinary approach	Pierantonio Laveneziana, Louis Laviolette
TF-2020-05	ERS Statement on airway clearance techniques in adults with bronchiectasis	Arietta Spinou, Beatriz Herrero-Cortina
TF-2020-03	ERS/EULAR Clinical practice guideline on connective tissue diseases with interstitial lung (ILD) involvement	Katerina Antoniou, Bruno Crestani, Anna-Maria Hoffmann-Vold, Oliver Distler
TF-2020-02	Technical standard on nasal nitric oxide measurement in children for the diagnosis of primary ciliary dyskinesis	Jane Lucas, Nicole Beydon
TF-2020-01	Developing Global Lung Function Initiative (GLI) reference equations for multiple breath washout	Alexandre Horsley, Kathryn Ramsey
TF-2019-21	Updated Technical Standards for the measurement of lung volumes	Bhakta Nirav, Aisling McGowan
TF-2019-18	Idiopathic Pulmonary Fibrosis (IPF) – An update of diagnosis and treatment recommendations: Official ATS/ERS/JRS/ALAT Clinical Practice Guidelines	Ganesh Raghu, Carey Thomson, Martine Remy-Jardin, Luca Richeldi
TF-2019-16	Technical Standards on scoring of respiratory events using type III devices for the diagnosis of sleep disordered breathing in adults and children	Renata Riha, Winfried Randerath
TF-2019-14	ERS/ESTS/ESTRO/ESR/ESTI Statement on management of incidental findings from low-dose CT screening for lung cancer (MILCa)	David Baldwin, Gilbert Massard
TF-2019-12	Statement on management of acute exacerbations of chronic obstructive pulmonary disease	Alexander Mathioudakis, Jens-Ulrich Jensen
TF-2019-10	A statement on the impact of genetics in pulmonary fibrosis	Raphael Borie, Coline Van Moorsel
TF-2019-09	Guidelines on transbronchial (cryo)biopsy and surgical lung biopsy in interstitial lung diseases	Venerino Poletti, Jouke Annema
TF-2019-05	Guidelines on management of spontaneous pneumothorax	Najib Rahman, Guiseppe Cardillo
TF-2019-03	Statement on dyspnoea in acutely ill mechanically ventilated patients	Alexandre Demoule, Leo Heunks
TF-2019-01	Statement on paediatric long-term NIV	Brigitte Fauroux, Stijn Verhulst
TF-2018-15	Statement on treatment of lung cancer stage 1A	Hans-Ulrich Kauczor, Nir Peled
TF-2018-14	Statement on Combined pulmonary fibrosis and emphysema (CPFE)	Vincent Cottin
TF-2018-11	Updated Technical Standards for interpretive strategies for basic lung function tests	Sanja Stanojevic, David Kaminsky
TF-2018-08	Statement on diagnosis and investigation of central sleep apnoea in children aged 1 month to 18 years	Hui-Leng Tan
TF-2018-07	Techincal Standards on Developing Lung Function Initiative (GLI) reference equations for exhaled and nasal nitric oxide	Anh-Tuan Dinh-Xuan, Graham Hall
TF-2018-02	Guidelines on giagnosis of asthma in adults	Louis Renaud, Usmani Omar
TF-2018-01	Guidelines on non-CPAP therapies for obstructive sleep apnoea	Winfried Randerath, Johan Verbraecken
TF-2017-04	ERS Statement for the Interpretation of Nitric Oxide Uptake in the Lung	Anh-Tuan Dinh-Xuan, Gerald Zavorsky
TF-2017-03	Guidelines on management of severe community acquired pneumonia	Antoni Torres, Ignacio Martin-Loeches

For latest published documents, visit the Guidelines section